Policy & Legislation
News on government policy and legislation impacting the life science and diagnostics markets.
Both short-read and long-read instrument makers are fleshing out their multiomics menus as they hope to gain a share of the fast-evolving market.
International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time
Researchers laid out a set of ethical, organizational, and technical guidelines for the development, commercial use, and clinical implementation of microbiome tests.
Association for Molecular Pathology 'In Limbo' as FDA Lawsuit Moves Ahead, LDT Regulations Loom
Premium
At the AMP annual meeting this week, leadership briefed members on what to expect as its lawsuit challenging the FDA final rule on laboratory-developed test regulation unfolds.
All of Us Program Looking to Public-Private Partnerships, Other Funding Amid Budget Uncertainty
Premium
In a report, a working group cautioned that the program must lessen its reliance on congressional appropriations or risk "squandering" investments made so far.
New Billing Code for Genetic Counselors Will Better Capture Time Spent on Patients, NSGC Says
Premium
At its annual meeting, NSGC also said the new code will further the organization's goal of securing better reimbursement for genetic counselors.